American Lung Association Launches Free Lung Cancer Screenings for Illinois Residents in Honor of Lung Cancer Awareness Month

November is Lung Cancer Awareness Month, and the American Lung Association (Lung Association) is kicking it off by offering free lung cancer screenings to&...

November 01, 2024 | Friday | News
Pangea Laboratory Partners with Unilabs to Launch Bladder CARE™ Assay in Switzerland

Pangea Laboratory has partnered with Unilabs, a leading European provider of clinical laboratory testing and diagnostic imaging services, to bring the Blad...

November 01, 2024 | Friday | News
Akeso Biopharma Initiates Phase III Study for Ivonescimab in Advanced Biliary Tract Cancer

Akeso Biopharma (9926.HK) is pleased to announce the successful enrollment of the first patient in the HARMONi-GI-01/AK112-309 study, a randomized, control...

November 01, 2024 | Friday | News
Eisai and Biogen Showcase Promising Long-Term Data for Lecanemab in Early Alzheimer’s Disease at CTAD 2023

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusett...

November 01, 2024 | Friday | News
Roche Unveils Promising Data for Elecsys Amyloid Plasma Panel in Alzheimer’s Diagnosis at CTAD 2024

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced new late-breaking data on its Elecsys Amyloid Plasma Panel (combination of pTau181 and ApoE4), for Alzhei...

November 01, 2024 | Friday | News
Novartis Secures FDA Accelerated Approval for Scemblix® in Newly Diagnosed CML Patients

Novartis announced that Scemblix® (asciminib) was granted accelerated approval by the US Food and Drug Administration (FDA) for adult patients wit...

October 30, 2024 | Wednesday | News
RemeGen's Taicercept® for Generalized Myasthenia Gravis Receives Priority Review from China’s Drug Administration

RemeGen Co. Ltd. ("RemeGen" or "the Company") (9995.HK, 688331.SH), a commercial-stage biotechnology company, recently announced that the marketing applica...

October 29, 2024 | Tuesday | News
AstraZeneca’s Fasenra Receives EU Approval as Add-On Treatment for Eosinophilic Granulomatosis with Polyangiitis

AstraZeneca’s Fasenra (benralizumab) has been approved in the European Union (EU) as an add-on treatment for adult patients with relapsing ...

October 29, 2024 | Tuesday | News
RiboX Therapeutics Secures FDA Clearance for First-Ever Circular RNA Therapy RXRG001 in Phase I/IIa Study

RiboX Therapeutics Ltd. (RiboX), a pioneering biopharmaceutical company, focused on discovering and developing fully engineered circular RNA therapeutics...

October 28, 2024 | Monday | News
Kind Pharmaceutical Secures FDA Orphan Drug Designation for Sickle Cell Disease Treatment AND017

Kind Pharmaceutical ("Hangzhou Andao Pharmaceutical Ltd. and Kind Pharmaceuticals LLC"), a clinical-stage biopharmaceutical company focused on developing...

October 28, 2024 | Monday | News
PROVISION Study Reveals FFRangio's Advantages Over Traditional Wire-Based FFR at TCT 2024

The Cardiovascular Research Foundation's annual Transcatheter Cardiovascular Therapeutics (TCT) conference taking place at the Walter E. Washington Convent...

October 28, 2024 | Monday | News
Adona Medical Achieves Milestone with First-in-Human Use of Novel Interatrial Shunt for Heart Failure

Adona Medical, a Shifamed portfolio company that aims to deliver advanced solutions for heart failure, announced the successful first-in-human use of ...

October 28, 2024 | Monday | News
European Commission Approves KEYTRUDA for New Indications in Gynecologic Cancers

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that the European Commission (EC) has approved two new indications for K...

October 25, 2024 | Friday | News
Eli Lilly’s Donanemab Receives MHRA Approval for Alzheimer's Treatment in Great Britain

Eli Lilly and Company (NYSE: LLY) announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization fo...

October 24, 2024 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close